| human | Q5 |
| P496 | ORCID iD | 0000-0002-2883-1282 |
| P108 | employer | Fudan University Shanghai Cancer Center | Q30296172 |
| P106 | occupation | researcher | Q1650915 |
| Q52639523 | A large-scale, exome-wide association study of Han Chinese women identifies three novel loci predisposing to breast cancer. |
| Q92501000 | Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trial |
| Q112649861 | Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis |
| Q57790433 | Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer |
| Q114109937 | High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes |
| Q90388825 | Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer |
| Q92125972 | Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity |
| Q98503966 | Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer |
| Q64059230 | The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation |
Search more.